Current Edition

Accelerating Clinical Research in Brazil

Clinical research is underdeveloped in Brazil, although the country
has the requisite expertise and infrastructure. Luis Magalhaes
and Le Vin Chin of Clinerion Ltd examine the situation and
trends in South America and Brazil. In particular, they look at
two developments which promise the acceleration of clinical
research in Brazil. First, the approval in the Senate of the PLS
200 law, which gives a framework for making clinical trials
approvals more efficient. Second, the initiatives for digitisation of
health data, which permits the use of new patient data analytics